Consciousness Disturbances Reported With Clindamycin Versus Cefazolin in Surgical Patients: A Global Pharmacovigilance Analysis Using <scp>VigiBase</scp>

Clindamycin is a common β-lactam substitute for surgical prophylaxis. Whether peri-operative disturbances in consciousness are disproportionately reported with clindamycin in global pharmacovigilance data remains unclear. Using WHO VigiBase (up to January 27, 2025), we performed a de-duplicated case/non-case disproportionality analysis of Individual Case Safety Reports (ICSRs) co-reporting ≥ 1 anesthetic or sedative. Cases were defined by the MedDRA HLT "Disturbances in consciousness NEC." We estimated RORs and aRORs for clindamycin versus cefazolin and other peri-operative comparators (metronidazole, vancomycin, ampicillin), adjusting for age group, sex, and co-reported medications. K-modes clustering characterized co-reporting patterns among clindamycin reports. Sensitivity analyses excluded sepsis-related terms/vasopressors and applied a narrower outcome definition excluding syncope/presyncope. Of 3623 clindamycin ICSRs, 159 (4.4%) included a consciousness-disturbance term. Versus cefazolin, clindamycin generated a disproportionality signal (ROR 2.59, 95% CI 2.07-3.24; aROR 2.23, 95% CI 1.70-2.91), with similar estimates after excluding sepsis/vasopressors (aROR 2.21, 95% CI 1.64-2.98) and syncope/presyncope (aROR 2.11, 95% CI 1.60-2.79). Clustering suggested co-reporting patterns consistent with lidocaine-enriched older-age reports, sedative/anesthetic-enriched younger-age reports, and opioid-enriched reports with high-acuity markers. In VigiBase, disproportionality analyses identified a reporting signal for disturbances in consciousness with clindamycin relative to cefazolin in surgical settings. Because spontaneous reports lack exposure denominators and are susceptible to residual confounding, these findings are hypothesis-generating and do not estimate incidence or comparative risk. Evaluation in data sources with denominators and prospective clinical characterization is warranted.

Authors

Institutions

Publication Details

Journal
Clinical and Translational Science
Published
2026-04-01
DOI
https://doi.org/10.1111/cts.70534
Primary Topic
Pharmacovigilance and Adverse Drug Reactions
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Consciousness Disturbances Reported With Clindamycin Versus Cefazolin in Surgical Patients: A Global Pharmacovigilance Analysis Using VigiBase

Basile Chrétien, Keita Hiraga, Daigo Tamakoshi, Tomoyuki Nakamura et al.
Clinical and Translational Science
Pharmacovigilance and Adverse Drug Reactions
article

Consciousness Disturbances Reported With Clindamycin Versus Cefazolin in Surgical Patients: A Global Pharmacovigilance Analysis Using VigiBase

Basile Chrétien, Keita Hiraga, Daigo Tamakoshi, Tomoyuki Nakamura, Masahisa Katsuno, Hiroshi Morioka, Shigeyuki Matsui, Kazuki Nishida, Yoshitaka Hara
article en

Abstract

Clindamycin is a common β-lactam substitute for surgical prophylaxis. Whether peri-operative disturbances in consciousness are disproportionately reported with clindamycin in global pharmacovigilance data remains unclear. Using WHO VigiBase (up to January 27, 2025), we performed a de-duplicated case/non-case disproportionality analysis of Individual Case Safety Reports (ICSRs) co-reporting ≥ 1 anesthetic or sedative. Cases were defined by the MedDRA HLT "Disturbances in consciousness NEC." We estimated RORs and aRORs for clindamycin versus cefazolin and other peri-operative comparators (metronidazole, vancomycin, ampicillin), adjusting for age group, sex, and co-reported medications. K-modes clustering characterized co-reporting patterns among clindamycin reports. Sensitivity analyses excluded sepsis-related terms/vasopressors and applied a narrower outcome definition excluding syncope/presyncope. Of 3623 clindamycin ICSRs, 159 (4.4%) included a consciousness-disturbance term. Versus cefazolin, clindamycin generated a disproportionality signal (ROR 2.59, 95% CI 2.07-3.24; aROR 2.23, 95% CI 1.70-2.91), with similar estimates after excluding sepsis/vasopressors (aROR 2.21, 95% CI 1.64-2.98) and syncope/presyncope (aROR 2.11, 95% CI 1.60-2.79). Clustering suggested co-reporting patterns consistent with lidocaine-enriched older-age reports, sedative/anesthetic-enriched younger-age reports, and opioid-enriched reports with high-acuity markers. In VigiBase, disproportionality analyses identified a reporting signal for disturbances in consciousness with clindamycin relative to cefazolin in surgical settings. Because spontaneous reports lack exposure denominators and are susceptible to residual confounding, these findings are hypothesis-generating and do not estimate incidence or comparative risk. Evaluation in data sources with denominators and prospective clinical characterization is warranted.

Clinical and Translational ScienceVol. 19(4)
Fujita Health University (JP), Kyoto University (JP), Nagoya City University (JP), Nagoya University Hospital (JP), Nagoya University (JP)
World Health Organization, Uppsala Monitoring Centre, Japan Society for the Promotion of Science
Good health and well-being
Openalex Percentile: Top 27%
Pharmacovigilance and Adverse Drug Reactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.